Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

17.63
+0.55003.22%
Post-market: 17.640.0100+0.06%19:48 EDT
Volume:2.45M
Turnover:43.10M
Market Cap:6.17B
PE:-18.16
High:17.84
Open:17.28
Low:17.21
Close:17.08
52wk High:24.28
52wk Low:1.33
Shares:349.76M
Float Shares:291.15M
Volume Ratio:0.97
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:17.04
PE(LYR):-40.14

Loading ...

Erasca sees ERAS-0015 Phase 1 monotherapy data by mid-May 2026

Reuters
·
Apr 21

ERAS: Promising RAS-Mutant Oncology Pipeline and China Partnership Support Buy Rating

TIPRANKS
·
Apr 14

Bar remains unchanged for Erasca after Revolution’s ‘clear win,’ says Jefferies

TIPRANKS
·
Apr 14

Erasca drops 9% to $15.54 after Revolution pancreatic cancer data

TIPRANKS
·
Apr 14

Erasca falls -10.6%

TIPRANKS
·
Apr 13

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM

Reuters
·
Apr 13

Erasca Chief Legal Officer Ebun Garner disposes of 80,000 shares for $1.3 million

Reuters
·
Apr 03

Analysts Conflicted on These Healthcare Names: Erasca (ERAS) and Mereo Biopharma Group Plc (MREO)

TIPRANKS
·
Mar 26

Erasca’s HERKULES-3 Trial Reaches Completion: What Investors Should Watch in ERAS-007

TIPRANKS
·
Mar 26

Erasca Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 18

Erasca price target raised to $25 from $24 at JPMorgan

TIPRANKS
·
Mar 18

Does Tango Therapeutics (TNGX) Trial Pact and ESOP Shelf Hint at a Pivotal Strategic Turn?

Simply Wall St.
·
Mar 17

Erasca Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 16

Erasca price target raised to $20 from $12 at Guggenheim

TIPRANKS
·
Mar 16

Mizuho Securities Remains a Buy on Erasca (ERAS)

TIPRANKS
·
Mar 15

Erasca Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Mar 14

Stock Track | Erasca Plummets 5.39% Intraday After Bank of America Maintains Sell Rating with $2 Target

Stock Track
·
Mar 14

Stock Track | Erasca Soars 5.12% Intraday on Positive Analyst Actions Including Price Target Hikes

Stock Track
·
Mar 13

Erasca Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 13

Mizuho Raises Price Target on Erasca to $19 From $16, Keeps Outperform Rating

MT Newswires Live
·
Mar 13